Why the study?
Does treatment with purinergic receptor (P2X7R) antagonists reverse impaired smooth muscle function caused by subfailure overstretch injury in rat abdominal aorta?
Does treatment with purinergic receptor (P2X7R) antagonists reverse impaired smooth muscle function caused by subfailure overstretch injury in rat abdominal aorta?
Subfailure overstretch injury in vascular tissue causes smooth muscle dysfunction that is partially reversible with P2X7R antagonists, suggesting a novel therapeutic target for surgical vascular stretch injury.
Hypothesis-generating rat aortic model for surgical stretch injury; leaves open human translation and prevention strategies.
Vascular stretch injury is associated with blunt trauma, vascular surgical procedures, and harvest of human saphenous vein for use in vascular bypass grafting. A model of subfailure overstretch in rat abdominal aorta was developed to characterize surgical vascular stretch injury. Longitudinal stretch of rat aorta was characterized ex vivo. Stretch to the haptic endpoint where the tissues would no longer lengthen, occurred at twice the resting length. The stress produced at this length was greater than physiologic mechanical forces but well below the level of mechanical disruption. Functional responses were determined in a muscle bath and this subfailure overstretch injury led to impaired smooth muscle function that was partially reversed by treatment with purinergic receptor (P2X7R) antagonists. These data suggest that vasomotor dysfunction caused by subfailure overstretch injury may be due to activation of P2X7R. These studies have implications for our understanding of mechanical stretch injury of blood vessels and offer novel therapeutic opportunities.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: